These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3242191)

  • 21. [High-dose cytarabine treatment: a promising therapy modality in acute resistant myeloid leukemias in recurrence].
    Meusers P; Heidemann H; Lunscken C; Uppenkamp M; Zou P; Brittinger G
    Onkologie; 1985 Feb; 8(1):16, 18-9. PubMed ID: 3885115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Results of treatment with 2 chemotherapeutic protocols (TAPA and VAPA) in acute myeloblastic leukemia].
    Avilés-Miranda A; Ambriz-Fernández R; García-Vela E; Monroy-Arellano L; Pizzuto J
    Gac Med Mex; 1984 Apr; 120(4):145-50. PubMed ID: 6593266
    [No Abstract]   [Full Text] [Related]  

  • 23. Bilateral ear Sweet's syndrome in a case with relapse acute myeloblastic leukemia.
    Disel U; Paydas S; Yavuz S; Tuncer I; Alpay R
    Leuk Res; 2006 Mar; 30(3):364. PubMed ID: 16157374
    [No Abstract]   [Full Text] [Related]  

  • 24. A homoharringtonine-based regimen for childhood acute myelogenous leukemia.
    Tang J; Xue H; Pan C; Chen J; Gu L; Zhao H
    Med Pediatr Oncol; 2003 Jul; 41(1):70-2. PubMed ID: 12764750
    [No Abstract]   [Full Text] [Related]  

  • 25. [Refractory acute myelogenous leukemia successfully treated with a continuous infusion chemotherapy of low dose aclarubicin and cytosine arabinoside: a case report].
    Kawada H; Komatsuda M; Masumoto A; Fukuda R; Watanabe S; Yonekura S; Ichikawa Y; Nagao T; Arimori S
    Rinsho Ketsueki; 1993 May; 34(5):667-9. PubMed ID: 8315839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FLAIE (fludarabine, cytarabine, idarubicin, and etoposide), a four drug induction chemotherapy for adult acute myeloid leukemia: A single center experience.
    Candoni A; Simeone E; Tiribelli M; Malagola M; Russo D; Fanin R
    Am J Hematol; 2009 Oct; 84(10):690-2. PubMed ID: 19731308
    [No Abstract]   [Full Text] [Related]  

  • 27. The value of combination therapy in adult acute myeloid leukemia with central nervous system involvement.
    Castagnola C; Nozza A; Corso A; Bernasconi C
    Haematologica; 1997; 82(5):577-80. PubMed ID: 9407724
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Modified VAPA therapy in children with acute nonlymphocytic leukemia].
    Morohashi F; Aonuma K; Katoh M; Kobayashi T; Hanaoka Y; Tsuji K; Norose N; Kawai H; Nakahata T; Tsukada M
    Rinsho Ketsueki; 1986 Nov; 27(11):2101-6. PubMed ID: 3820627
    [No Abstract]   [Full Text] [Related]  

  • 29. Direct morphological evidence of high-dose methylprednisolone-induced maturation of leukemic cells in children with acute nonlymphoblastic leukemia.
    Hiçsönmez G; Ozsoylu S; Tuncer AM; Ertürk G; Ozbek N; Karadeniz N
    Exp Hematol; 1991 Mar; 19(3):232-3. PubMed ID: 1995314
    [No Abstract]   [Full Text] [Related]  

  • 30. High-dose methylprednisolone for remission induction in children with acute nonlymphoblastic leukemia.
    Hiçsönmez G; Ozsoylu S; Gürgey A; Zamani VP; Irken G
    Eur J Haematol; 1989 May; 42(5):498-500. PubMed ID: 2731596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Results of treatment with an intensive combination induction regimen containing idarubicin in children with acute myeloblastic leukemia: preliminary report of the Argentine Group for Treatment of Acute Leukemia.
    Sackmann-Muriel F; Fernández-Barbieri MA; Santarelli MT; Matus-Ridley M; Rosso A; Negri-Aranguren P; Cerutti I; Gomel M; Kvicala R
    Semin Oncol; 1993 Dec; 20(6 Suppl 8):34-8. PubMed ID: 8290970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mitoxantrone and cytarabine induction, high-dose cytarabine, and etoposide intensification for pediatric patients with relapsed or refractory acute myeloid leukemia: Children's Cancer Group Study 2951.
    Wells RJ; Adams MT; Alonzo TA; Arceci RJ; Buckley J; Buxton AB; Dusenbery K; Gamis A; Masterson M; Vik T; Warkentin P; Whitlock JA;
    J Clin Oncol; 2003 Aug; 21(15):2940-7. PubMed ID: 12885813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Idarubicin plus continuous-infusion high-dose cytarabine as treatment for patients with acute myelogenous leukemia or myelodysplastic syndrome.
    Estey EH; Kantarjian H; Keating M
    Semin Oncol; 1993 Dec; 20(6 Suppl 8):1-5. PubMed ID: 8290966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Arsenic trioxide and low-dose cytarabine in older patients with untreated acute myeloid leukemia, excluding acute promyelocytic leukemia.
    Roboz GJ; Ritchie EK; Curcio T; Provenzano J; Carlin R; Samuel M; Wittenberg B; Mazumdar M; Christos PJ; Mathew S; Allen-Bard S; Feldman EJ
    Cancer; 2008 Nov; 113(9):2504-11. PubMed ID: 18825661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessing prognosis in acute leukemia.
    Cavdar AO; Gözdaşoğlu S; Babacan E
    Am J Pediatr Hematol Oncol; 1990; 12(2):241-3. PubMed ID: 2378419
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment of primary acute myeloid leukemia: results of a prospective multicenter trial including high-dose cytarabine or stem cell transplantation as post-remission strategy.
    Brunet S; Esteve J; Berlanga J; Ribera JM; Bueno J; Martí JM; Bargay J; Guardia R; Juliá A; Granena A; Montserrat E; Sierra J;
    Haematologica; 2004 Aug; 89(8):940-9. PubMed ID: 15339677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of modified FLAG regimen therapy on 33 patients with relapsed/refractory leukemia].
    Meng FY; Yang LJ; Xu B; Liu XL; Zheng WY; Zhang Y; Huang F; Sun J; Liu QF
    Ai Zheng; 2003 Dec; 22(12):1330-3. PubMed ID: 14693062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Acute leukemia in children and ocular involvement].
    Hatae Y; Takeda T; Hattori T; Nakadate H; Nishi M; Kobayashi R; Konno M
    Rinsho Ketsueki; 1986 Mar; 27(3):420-5. PubMed ID: 3461183
    [No Abstract]   [Full Text] [Related]  

  • 39. [Preliminary results of intensive care of acute myeloid leukemia in children under 2 therapeutic protocols].
    Cáp J; Foltinová A; Misíková Z
    Cesk Pediatr; 1984 Sep; 39(9):509-12. PubMed ID: 6595070
    [No Abstract]   [Full Text] [Related]  

  • 40. Intensive induction chemotherapy with regimen containing intermediate dose cytarabine in the treatment of de novo acute myeloid leukemia.
    Liu J; Mi Y; Fu M; Yu W; Wang Y; Lin D; Bian S; Wang J
    Am J Hematol; 2009 Jul; 84(7):422-7. PubMed ID: 19484734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.